(Q28303840)

English

Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis

scientific article

Prevalence of anti-N-methyl-d-aspartate (NMDA) receptor antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24330811%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24330811%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24330811%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24330811%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

T A Pollak

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24330811%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

R McCormack

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24330811%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

A S David

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24330811%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

0 references

publication date

13 December 2013

2 references

DOI.org query endpoint

https://doi.org/10.1017%2FS003329171300295X

25 March 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24330811%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Psychological Medicine

2 references

DOI.org query endpoint

https://doi.org/10.1017%2FS003329171300295X

25 March 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24330811%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

44

2 references

DOI.org query endpoint

https://doi.org/10.1017%2FS003329171300295X

25 March 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24330811%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

12

2 references

DOI.org query endpoint

https://doi.org/10.1017%2FS003329171300295X

25 March 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24330811%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

2475-2487

2 references

DOI.org query endpoint

https://doi.org/10.1017%2FS003329171300295X

25 March 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24330811%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://api.crossref.org/works/10.1017/S003329171300295X

21 April 2017

Antibody-mediated encephalitis: a treatable cause of schizophrenia

1 reference

https://api.crossref.org/works/10.1017/S003329171300295X

21 April 2017

Disease-relevant autoantibodies in first episode schizophrenia

1 reference

https://api.crossref.org/works/10.1017/S003329171300295X

21 April 2017

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

1 reference

https://api.crossref.org/works/10.1017/S003329171300295X

21 April 2017

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

1 reference

https://api.crossref.org/works/10.1017/S003329171300295X

21 April 2017

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis

1 reference

https://api.crossref.org/works/10.1017/S003329171300295X

21 April 2017

Antibodies in epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

A clinical and neurobiological case of IgM NMDA receptor antibody associated encephalitis mimicking bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Antibodies to infectious agents in individuals with recent onset schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

NMDA receptor antibodies predict adverse neurological outcome after cardiac surgery in high-risk patients.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Maternal antibodies to infectious agents and risk for non-affective psychoses in the offspring--a matched case-control study.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Systemic lupus erythematosus, the brain, and anti-NR2 antibodies

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Neuronal autoantigens--pathogenesis, associated disorders and antibody testing

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Schizophrenia and HLA: a review

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Autoimmune diseases and infections as risk factors for schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

NR2 antibodies: risk assessment of transient ischemic attack (TIA)/stroke in patients with history of isolated and multiple cerebrovascular events.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Updating the mild encephalitis hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Childhood infection and adult schizophrenia: a meta-analysis of population-based studies

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

A computational neuroscience approach to schizophrenia and its onset

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Cognitive deficits following anti-NMDA receptor encephalitis

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: an etiology worth considering in the differential diagnosis of delirium

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

When the drugs don't work: the potential of glutamatergic antipsychotics in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

A combined marker of inflammation in individuals with mania

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Memantine and catatonia: a case report and literature review

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Dopamine synthesis capacity in patients with treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Catatonia: Clinical Aspects and Neurobiological Correlates

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Increased prevalence of antibrain antibodies in the sera from schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Anti-inflammatory treatment in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Late onset autism and anti-NMDA-receptor encephalitis

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Glutamatergic model psychoses: prediction error, learning, and inference

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

21 January 2018

Antibody-mediated encephalitis and psychosis

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

7 January 2021

based on heuristic

inferred from DOI database lookup

Catatonia: clinical aspects and neurobiological correlates

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of anti-NMDA receptor autoantibodies in the serum of subjects with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies to the glutamate receptor in mania

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

7 January 2021

based on heuristic

inferred from DOI database lookup

Investigation of antibodies against synaptic proteins in a cross-sectional cohort of psychotic patients

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

7 January 2021

based on heuristic

inferred from DOI database lookup

NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rediscovering catatonia: the biography of a treatable syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

7 January 2021

based on heuristic

inferred from DOI database lookup

The computational anatomy of psychosis

1 reference

https://api.crossref.org/works/10.1017%2FS003329171300295X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S003329171300295X

3 references

DOI.org query endpoint

https://doi.org/10.1017%2FS003329171300295X

25 March 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24330811%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24330811%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28303840&oldid=1473987845"